Actavis reintroduces Oxycodone in the US

Little Falls facility resumes production with FDA approval of critical pain solution Reykjavik, Iceland, 17 April 2009 -- Actavis Group, the international generic pharmaceuticals company, today announced the reintroduction by its subsidiary in the United States of Oxycodone 15 mg and 30 mg tablet products to pharmacies and customers. Oxycodone is ... Read More...

Actavis formally launched in France

Actavis in France was formally launched on 23rd October at a one-day conference held at the Centre Étoile-Saint Honoré, close to the Champs Elysées in Paris. Actavis started preparing its greenfield operation in France in 2007, to market and sell Actavis products on the French market. The Group’s offices in the ... Read More...

Actavis and Medis represented at CPhI

Actavis Group employees from diverse departments from all over the world will be present at this year's annual CPhI conference, held in Frankfurt, Germany, 30 September to 2 October. Actavis' third party sales division, Medis, had its own stand at the CPhI exhibition for 8 years, but shared the floor with ... Read More...

Actavis announces senior appointments

Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international generic drug company, has announced that it has appointed Gudbjorg Edda Eggertsdottir as Deputy CEO. Valur Ragnarsson will become the new Executive Vice President of Third-Party Sales ... Read More...

Actavis first to market generic prostate cancer drug Bicalutamide in the UK, Germany & France

Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the oncology drug to be made available in the three markets. Actavis has launched a generic drug for prostate cancer, Bicalutamide, in the UK, France and Germany. Bicalutamide, ... Read More...

Actavis supports cause of disabled access in Bulgaria

The Iceland-based generic drugs manufacturer Actavis announces the opening of a new disabled access ramp to a major Bulgarian cathedral. Actavis has financed the construction of an access ramp for disabled people to a large cathedral in Bulgaria. The ramp was officially opened by Nikolay Hadjidonchev, Actavis’ Bulgaria Managing director, in ... Read More...